Skip to main content

Advertisement

Log in

Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy

  • Original Article
  • Published:
Annals of Hematology Aims and scope Submit manuscript

Abstract

Skeletal X-ray survey is the established method of diagnosis in patients with multiple myeloma; however, whole-body magnetic resonance imaging (wb-MRI) has become an important additional tool. The aim of this study was to compare the different patterns of infiltration on conventional X-ray examinations (X-ray survey) with findings from wb-MRI to subsequently determine the influence of wb-MRI on therapy changes. In 60 patients with a mean age of 65.1 ± 11.7 years, wb-MRI examinations were correlated with a recent X-ray survey. The results were independently assessed by two radiologists and the patterns of infiltration were described in both modalities. Subsequently, the disease was staged according to Salmon and Durie and Salmon and Durie PLUS. Additionally, the influence of MRI on potential changes in therapy was assessed using a three-range Likert-type scale. In all, 480 skeletal regions were compared. In 183 skeletal regions, an increased degree of infiltration was identified on wb-MRI. Significant differences (p < 0.05) between the modalities could be found in the thorax, spine, pelvis, and both lower extremities. Based on wb-MRI, tumor stage was upgraded in 19 of the 60 patients using the Durie and Salmon PLUS classification. In ten out of these 19 patients (42%), the wb-MRI result was essential for making the decision to initiate further therapy due to the degree of infiltration, extramedullary tumor extension, and/or further risk of fracture. Whole-body MRI provides a more detailed assessment of the pattern of bone marrow infiltration and strongly influences therapeutic strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Kelly JJ (1999) Neuropathies of monoclonal gammopathies of undetermined significance. Hematol Oncol Clin North 13(6):1203–1210

    Article  CAS  Google Scholar 

  2. Baur A, Stäbler A, Nagel D, Lamerz R, Bartl R, Hiller E, Wendtner C, Bachner F, Reiser M (2002) Magnetic resonance imaging as a supplement for the clinical staging system of Durie und Salmon? Cancer 95(6):1334–1345

    Article  PubMed  Google Scholar 

  3. Durie BG (2006) The role of anatomic and functional staging in myeloma: description of Durie/Salmon plus staging system. Eur J Cancer 42(11):1539–1543

    Article  PubMed  Google Scholar 

  4. Durie BG, Kyle RA, Belch A, Bensinger W, Blade J, Boccadoro M, Child JA, Comenzo R, Djulbegovic B, Fantl D, Gahrton G, Harousseau JL, Hungria V, Joshua D, Ludwig H, Mehta J, Morales AR, Morgan G, Nouel A, Oken M, Powles R, Roodman D, San Miguel J, Shimizu K, Singhal S, Sirohi B, Sonneveld P, Tricot G, Van Ness B, Scientific Advisors of the International Myeloma Foundation (2003) Myeloma management guidelines, a consensus report from the Scientific Advisors of International Myeloma Foundation. Hematol J 4(6):379–398

    Article  PubMed  Google Scholar 

  5. Durie BG, Salmon SE (1975) A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 36(3):842–854

    Article  PubMed  CAS  Google Scholar 

  6. Baur A, Stäbler A, Bartl R, Lamerz R, Reiser M (1996) Infiltration patterns of plasmacytomas in magnetic resonance tomography. RoFo 164(6):457–463

    PubMed  CAS  Google Scholar 

  7. Baur-Melnyk A, Buhmann S, Dürr HR, Reiser M (2005) Role of MRI for the diagnosis and prognosis of multiple myeloma. Eur J Radiol 55(1):56–63

    Article  PubMed  Google Scholar 

  8. Eustace S, Tello R, Decarvalho V, Carey J, Wroblicka JT, Melhem ER, Yucel EK (1997) A comparison of whole body turbo STIR MR imaging and planar 99Tc-methylene diphosphonate scintigraphy in the examination of patients with suspected skeletal metastases. AJR Am J Roentgenol 169(6):1655–1661

    PubMed  CAS  Google Scholar 

  9. Lecouvet FE, Vande Berg BC, Michaux L, Malghem J, Maldague BE, Jamart J, Ferrant A, Michaux JL (1998) Stage III multiple myeloma: clinical and prognostic value of spinal bone marrow MR imaging. Radiology 209(3):653–660

    PubMed  CAS  Google Scholar 

  10. Lecouvet FE, Malghem J, Michaux L, Michaux JL, Lehmann F, Maldague BE, Jamart J, Ferrant A, Vande Berg BC (1997) Vertebral compression fractures in multiple myeloma. Part II. Assessment of fracture risk with MR imaging of spinal bone marrow. Radiology 204(1):201–205

    PubMed  CAS  Google Scholar 

  11. Mariette X, Zagdanski AM, Guermazi A, Bergot C, Arnould A, Frija J, Brouet JC, Fermand JP (1999) Prognostic value of vertebral lesions detected by magnetic resonance imaging in patients with stage I multiple myeloma. Br J Haematol 104:723–729

    Article  PubMed  CAS  Google Scholar 

  12. Steinborn M, Tilling R, Heuck A, Brügel M, Gauger L, Reiser M (1999) Whole-body bone marrow MRI in patients with metastatic disease to the skeletal system. J Comput Assist Tomogr 23:123–129

    Article  PubMed  CAS  Google Scholar 

  13. Baur A, Bartl R, Pellengahr C, Baltin V, Reiser M (2004) Neovascularization of bone marrow in patients with diffuse multiple myeloma: a correlative study of magnetic resonance imaging and histologic findings. Cancer 101:2599–2604

    Article  PubMed  Google Scholar 

  14. Lecouvet FE, Malghem JL, Michaux L, Maldague B, Ferrant A, Michaux JL, Vande Berg BC (1999) Skeletal survey in advanced multiple myeloma: radiography versus MRI survey. Br J Haematol 106(1):35–39

    Article  PubMed  CAS  Google Scholar 

  15. Ghanem N, Altehöffer C, Högerle S, Schäfer O, Winterer J, Moser E, Langer M (2002) Comparative diagnostic value and therapeutic relevance of magnetic resonance imaging and bone marrow scintigraphy in patients with metastatic solid tumor of axial skeleton. Eur J Radiol 43(3):256–261

    Article  PubMed  Google Scholar 

  16. Ghanem N, Uhl M, Brink I, Schafer O, Kelly T, Moser E, Langer M (2005) Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 55(1):41–55

    Article  PubMed  CAS  Google Scholar 

  17. Schäfer FJ, Fischmann A, Lichy M, Vollmar J, Fenchel M, Claussen CD, Schlemmer HP (2004) Oncologic screening with whole-body MRI: possibilities and limitations. Radiologe 44:854–863

    Article  PubMed  Google Scholar 

  18. Ghanem N, Lohrmann C, Engelhard M, Pache G, Uhl M, Saueressig U, Kotter E, Langer M (2006) Whole-body MRI in the detection of bone marrow infiltration in patients with plasma cell neoplasms in comparison to radiologic skeletal survey. Eur Radiol 16(5):1005–1014

    Article  PubMed  Google Scholar 

  19. Bowker AH (1948) A test for symmetry in contingency tables. J Am Stat Assoc 43:572–574

    Article  PubMed  CAS  Google Scholar 

  20. Ludwig H, Frühwald F, Tscholakoff D, Rasoul S, Neuhold A, Fritz E (1987) Magnetic resonance imaging of the spine in multiple myeloma. Lancet 2(8555):364–366

    Article  PubMed  CAS  Google Scholar 

  21. Frühwald F, Tscholakoff D, Schwaighofer B, Wicke L, Neuhold A, Ludwig H, Hajek PC (1988) MRI of the lower vertebral column in patients with multiple myeloma. Invest Radiol 23(3):193–199

    Article  Google Scholar 

  22. Vacca A, Ribatti D, Roccaro AM, Frigeri A, Dammacco F (2001) Bone marrow angiogenesis in patients with active multiple myeloma. Semin Oncol 28(6):543–550

    Article  PubMed  CAS  Google Scholar 

  23. Vande Berg BC, Lecouvet FE, Michaux L, Labaisse M, Malghem J, Jamart J, Maldague BE, Ferrant A, Michaux JL (1996) Stage I multiple myeloma: value of MRI in the bone marrow in the determination of prognosis. Radiology 201(1):243–246

    CAS  Google Scholar 

  24. Vande Berg BC, Michaux L, Lecouvet FE, Labaisse M, Malghem J, Jamart J, Maldague BE, Ferrant A, Michaux JL (1997) Nonmyelomatous monoclonal gammopathy: correlation of bone marrow MR images with laboratory findings and spontaneous clinical outcome. Radiology 202(1):247–251

    PubMed  CAS  Google Scholar 

  25. Moulopoulos LA, Dimopoulos MA, Smith TL, Weber DM, Delasalle KB, Libshitz HI, Alexanian R (1995) Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma. J Clin Oncol 13(1):251–256

    PubMed  CAS  Google Scholar 

  26. Walker R, Barlogie B, Haessler J, Tricot G, Anaissie E, Shaughnessy JD Jr, Epstein J, van Hemert R, Erdem E, Hoering A, Crowley J, Ferris E, Hollmig K, van Rhee F, Zangari M, Pineda-Roman M, Mohiuddin A, Yaccoby S, Sawyer J, Angtuaco EJ (2007) Magnetic resonance imaging in multiple myeloma: diagnostic and clinical implications. J Clin Oncol 25(9):1121–1128

    Article  PubMed  Google Scholar 

  27. Antoch G, Vogt FM, Bockisch A, Rühm SG (2004) Whole-body tumor staging: MRI or FDG–PET/CT? Radiologe 44(9):882–888

    Article  PubMed  CAS  Google Scholar 

  28. Baur A, Stäbler A, Steinborn M, Schnarkowski P, Pistitsch C, Lamerz R, Bartl R, Reiser M (1998) Magnetic resonance tomography in plasmacytoma: ranking of various sequences in diffuse and focal infiltration patterns. RoFo 168(4):323–329

    PubMed  CAS  Google Scholar 

  29. Moulopoulos LA, Dimopoulos MA (1997) Magnetic resonance imaging of bone marrow in haematologic malignancies. Blood 90(6):2127–2147

    PubMed  CAS  Google Scholar 

  30. Baur-Melnyk A, Reiser M (2004) Staging of multiple myeloma with MRI: comparison to MSCT and conventional radiography. Radiologe 44(9):874–881

    Article  PubMed  CAS  Google Scholar 

  31. Rahmouni A, Divine M, Mathieu D, Golli M, Dao TH, Jazaerli N, Anglade MC, Reyes F, VasiIe N (1993) Detection of multiple myeloma involving the spine: efficacy of fat-suppression and contrast-enhanced MR-imaging. AJR Am J Roentgenol 160(5):1049–1052

    PubMed  CAS  Google Scholar 

  32. Wasser K, Möhler T, Nosas-Garcia S, Rehm C, Bartl R, Goldschmidt JH, Düber C, Kauczor HU, Delorme S (2005) Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma. RoFo 177(8):1116–1122

    PubMed  CAS  Google Scholar 

  33. Buss DH, Prichard RW, Hartz JW, Cooper MR, Feigin GA (1986) Initial bone marrow findings in multiple myeloma. Significance of plasma cell nodules. Arch Pathol Lab Med 110(1):30–33

    PubMed  CAS  Google Scholar 

  34. Schmidt GP, Baur A, Stäbler A, Schönberg SO, Steinborn M, Baltin V, Reiser MF (2005) Estimation of diffuse bone marrow infiltration of the spine in multiple myeloma: correlation of MRT with histological results. RoFo 177(5):745–750

    PubMed  CAS  Google Scholar 

  35. Rahmouni A, Divine M, Mathieu D, Golli M, Hajoun C, Dao T, Anglade MC, Reyes F, Vasile N (1993) MR appearance of multiple myeloma of the spine before and after treatment. AJR Am J Roentgenol 160(5):1053–1057

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dietmar Jörg Dinter.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dinter, D.J., Neff, W.K., Klaus, J. et al. Comparison of whole-body MR imaging and conventional X-ray examination in patients with multiple myeloma and implications for therapy. Ann Hematol 88, 457–464 (2009). https://doi.org/10.1007/s00277-008-0621-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-008-0621-6

Keywords

Navigation